Notified in December 2023, the revised Schedule M has shifted the focus from “good manufacturing practices” to “good ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion ...

What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights. Here’s your yearly recap—the most ...

Discover why pharma sector leaders and AI innovation may drive the S&P 500 to 9,000 by 2026. Explore top stocks, growth ...

Apellis Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...

The deal announced Friday tacks on to similar reduced price agreements the Trump administration has made with five other ...

Check out a month-by-month breakdown of the major events affecting the pharma and medical marketing industries in 2025.

Traws Pharma reports interim Phase 2 data showing ratutrelvir performed comparably to Paxlovid in mild-to-moderate COVID-19 ...

Large pharmaceutical companies are entering a period of renewed relevance as therapeutic innovation accelerates, particularly ...

Martin Shkreli, the notorious former CEO of Turing Pharmaceuticals and convicted securities fraudster, will still be banned from working in the pharmaceutical industry after a federal appeals court in ...